SASH3: A Drug Target / Disease Biomarker (G54440)

Target Name: SASH3

NCBI ID: G54440

SASH3

SASH3: A Drug Target / Disease Biomarker

SASH3 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell growth and has been implicated in a number of diseases, including cancer. As a drug target or biomarker, SASH3 is a focus of ongoing research and development, with several companies and researchers actively pursuing research in this area.

SASH3 is a member of the SAS-family of proteins, which are known for their role in regulating cell growth and apoptosis, or programmed cell death. The SAS-family proteins are involved in a number of cellular processes, including cell division, differentiation, and survival. SASH3 is specifically involved in the regulation of cell growth and in the control of apoptosis.

SASH3 is expressed in a wide range of tissues throughout the body, including the brain, heart, and kidneys. It is highly expressed in the brain, with lower levels of expression found in other tissues. SASH3 is also expressed in various cell types, including cancer cells. This makes it an attractive target for cancer therapies, as it can be used to inhibit the growth and survival of cancer cells.

In addition to its role in cell growth and apoptosis, SASH3 is also involved in the regulation of cell-cell adhesion. This is important for the development and maintenance of tissues and organs, as well as for the regulation of various physiological processes, including blood vessel formation and tissue repair. SASH3 is also involved in the regulation of cell-cell interactions, which are critical for the development and maintenance of tissues and organs during development and throughout life.

SASH3 has also been implicated in a number of diseases, including cancer. Its involvement in cancer development and progression makes it an attractive target for cancer therapies. SASH3 has been shown to be involved in the regulation of various cellular processes that are critical for cancer development, including the regulation of cell growth, apoptosis, and cell-cell adhesion. It has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This makes it an attractive target for therapies that are designed to inhibit the development and progression of cancer.

In addition to its potential as a cancer target, SASH3 is also a potential biomarker for a number of diseases. Its expression has been shown to be involved in the regulation of various physiological processes, including cell growth, apoptosis, and cell-cell adhesion. This makes it an attractive target for the development of diagnostic tests for a wide range of diseases. SASH3 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This makes it an attractive target for therapies that are designed to inhibit the development and progression of cancer.

SASH3 is also a target for several drugs that are currently in development for a variety of diseases. These drugs include inhibitors of SASH3's activity, as well as drugs that target SASH3 in a different way. Some of the most promising of these drugs are in the process of being tested in clinical trials, with the goal of using them to treat a wide range of diseases.

Overall, SASH3 is an attractive drug target and biomarker due to its involvement in cell growth, apoptosis, and cell-cell adhesion, as well as its potential involvement in the regulation of cancer development and progression. Its high expression in various tissues, including the brain, makes it an attractive target for therapies that are designed to inhibit its activity. As research continues to progress in this area, it is likely that we will see the development of a wide range of new treatments for a variety of diseases.

Protein Name: SAM And SH3 Domain Containing 3

Functions: May function as a signaling adapter protein in lymphocytes

The "SASH3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SASH3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets